Nurses Share New Ways to Prevent and Manage Difficult Side Effects in Cancer Care
Managing toxicities and adverse events (AEs) so that patients can continue to stay on effective treatments is essential to improving outcomes. Catherine Hill, BSN, RN, OCN®, Margaret Blaney, RN, BSN, Ashley Layton, BSN, RN, OCN®, and Kaddie Lopez, BSN, RN, OCN®, PHN, discussed ways to manage and prevent symptoms in cancer care during a session at the 43rd Annual Congress in Washington, DC.
Nurse Management of cGVHD in Patients on Ibrutinib Focuses on Education
Ibrutinib is a first-in-class, once-daily inhibitor of Bruton’s tyrosine kinase. In 2017, the U.S. Food and Drug Administration approved ibrutinib for the treatment of adult patients with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
Instructional Class Improves CAR T-Cell Knowledge in ICU and BMT Nurses
Chimeric antigen receptor T-cell (CAR T-cell) therapy has become an integral part of the advancement of lymphoma and other cancer treatments. However, educational resources and available published literature are still lacking for oncology and intensive care nurses.
Electronic Health Records Provide a Link Between Patient Data and Care Outcomes
Electronic health records (EHRs) can offer so much more than a way to keep all processes and procedures linked to a patient. Christina Boord, BSN, RN, OCN®, and Cori Kopecky, MSN, RN, OCN®, discussed electronic health records, patient data, and outcomes during a session at the 43rd Annual Congress in Washington, DC.
APNs Give Practical Advice for Establishing Clinics and Implementing Programs
Advanced practice nurses (APNs) are creating new and innovative programs that educate patients and help them live better, healthier lives. Lorraine Drapek, DNP, FNP-BC, AOCNP®, Geline Joy Tamayo, MSN, RN, ACNS-BC, OCN®, TTS, Suzanne McGettigan, MSN, CRNP, AOCN®, ANP-BC, and Edward Bentlyewski, MSN, APN, NP-C, AOCNP®, discussed their experiences with APN-run clinics and program implementation during a session at the 43rd Annual Congress in Washington, DC.
Nurses Are Using Quality Care to Improve Patient Outcomes
Staying updated on advancements in cancer care increases the chances of improved outcomes for patients. Cara Henderson, RN, BSN, CMSRN, patient service manager of surgical oncology at Smilow Cancer Hospital in New Haven, CT; Elizabeth Rodriguez, DNP, RN, OCN®, nurse leader of outpatient services at Memorial Sloan Kettering Cancer Center in New York, NY, Amanda Choflet, DNP, RN, OCN®, director of nursing in radiation oncology at Johns Hopkins Health System in Baltimore, MD, and Megan Howe, MSN, RN, OCN®, nurse manager of Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center in Lebanon, NH, discussed the factors that relate to improving outcomes, the multidisciplinary approaches to the process change strategy, and the results and future direction of chosen pathways during a session at the 43rd Annual Congress in Washington, DC.
Genomics Is Revolutionizing Cancer Care Now and For the Future
As precision oncology continues to expand, so does the ability to use less-toxic targeted therapies. James Chen, MD, assistant professor of biomedical informatics and assistant professor of internal medicine at the division of medical oncology at Ohio State University in Columbus, described his work with genomics in cancer care and the challenges in precision medicine at the 43rd Annual Congress in Washington, DC.
Drug Offers Extended Adjuvant Treatment Option for HER2+ Metastatic Breast Cancer
An estimated 266,120 new cases of invasive breast cancer and 40,920 related deaths will occur in the United States in 2018. Patients with distant disease have a poorer five-year relative survival rate (26.9%) compared with localized (98.9%) and regional (85.2%) disease. HER2+ breast cancer accounts for approximately 20%–25% of all breast cancer diagnoses, and this type of breast cancer is more common in younger women, decreasing in frequency with age across all stages.
Pharmacology Update Session Gives Oncology Nurses the Essentials on New Drug Approvals
If it seems like a new oncology drug or indication comes to market every month, you wouldn’t be wrong. The U.S. Food and Drug Administration (FDA) has approved a record number of oncology agents in 2017 and 2018. Teresa Knoop, MSN, RN, AOCN®, assistant director of clinical operations at the Clinical Trials Shared Resource at Vanderbilt-Ingram Cancer Center in Nashville, TN, gave an update on the latest therapies during a session at the 43rd Annual Congress in Washington, DC.
Oncology Nurses Have a Responsibility to Identify and Prevent Opioid Abuse in Patients With Cancer
As the opioid abuse epidemic prevails in the United States, patients with cancer can be affected. Yu-Ping Chang, PhD, RN, FGSA, associate dean for research and scholarship in the School of Nursing at the University at Buffalo in New York, and Tonya Edwards, MS, MSN, BSN, FNP-C, a nurse practitioner of supportive care at MD Anderson Cancer Center in Houston, TX, discussed how the opioid epidemic affects patients and how to identify and prevent opioid and substance abuse during a session at the 43rd Annual Congress in Washington, DC.
Better Care Is Needed to Manage Oral Cavity Symptoms of Chronic Graft-Versus-Host Disease
During the State-of-the-Science Lecture at the 43rd Annual Congress in Washington, DC, Jane Fall-Dickinson, PhD, RN, AOCN®, of Georgetown University School of Nursing and Health Studies, discussed chronic graft-versus-host disease (cGVHD), specifically its oral cavity complications. She presented challenges, clinical data, and goals for improving its treatment and management options.
Tips for Creating a Multidisciplinary Research Team Focused on Symptom Management
Catherine Bender, PhD, RN, FAAN, of the University of Pittsburgh, and Amy Hoffman, PhD, RN, of Michigan State University, shared their experiences in building interdisciplinary research teams to assess symptom management during a session at the 43rd Annual Congress in Washington, DC.
The Power of a Nurse: The Mara Mogensen Flaherty Memorial Lectureship
Margaret Bevans, PhD, RN, AOCN®, FAAN, program director and clinical nurse scientist at the National Institutes of Health’s Nursing Research and Translational Science department, detailed her own journey and empowered nurses to amplify their impact during her Mara Mogensen Flaherty Memorial lecture at the 43rd Annual Congress in Washington, DC.
Understanding Genomics and Using Precision Medicine to Advance Cancer Survival
During the American Association for Cancer Research/ONS Bench to Bedside session at the 43rd Annual Congress in Washington, DC, Victor Velculescu, MD, PhD, of Johns Hopkins University School of Medicine, and Maura Kadan, RN, MSN, of Personal Genome Diagnostics, dissected the science behind precision oncology, including an understanding of genetic alterations, the use of immunotherapy, and how to advance survival with these clinical breakthroughs.
Managing Immunotherapy-Related Adverse Events
Immunotherapy is becoming an important role in cancer care and having an understanding of immune-related adverse events (irAEs) is critical for oncology nurses to provide safe and effective patient care. Rowena Schwartz, PharmD, BCOP, of the University of Cincinnati in Ohio, discussed strategies for managing these AEs during a session at the 43rd Annual Congress in Washington, DC.
Geographic Health Disparities Affect Access to Clinical Trials
Geographic location impacts life expectancy and even cancer care. Marylynn Ostrowski Ireland, PhD, of Viability, Inc., and Deborah Watkins Bruner, PhD, RN, FAAN, of Emory University in Atlanta, GA, discussed geographic health disparities during a session at the 43rd Annual Congress in Washington, DC.
Immunotherapy Opens New Frontiers in Lung Cancer Care
The development of targeted therapies brought new progress to lung cancer treatment and research in the past 20 years, and new options will continue to be available in the future. Roy Herbst, MD, PhD, director of thoracic oncology research program at the Yale Comprehensive Cancer Center at Yale School of Medicine in New Haven, CT, spoke at the 43rd Annual Congress in Washington, DC, on new standards of care for non-small cell lung cancer (NSCLC), immunotherapy for NSCLC, and development of rational drug combinations using biomarkers.
Opioids Are Not Always the Answer
As the opioid crisis continues in the United States, helping patients find effective and safer ways to manage their pain becomes increasingly important. During a session at the 43rd Annual Congress in Washington, DC, Jeannine Brant, PhD, APRN, AOCN®, FAAN, of Billings Clinic in Montana, instructed nurses on ways to treat cancer-related pain and discomforts other than (or in addition to) narcotic pain medicines.
Nurses Are Advancing Research in Data-Powered Science
Nurses can foster data-powered health through getting involved in research and ensuring that data collection is in patients’ best interest and accessible to all. Patricia Brennan, PhD, RN, director of the National Library of Medicine, and Suzanne Bakken, PhD, RN, FAAN, a professor at Columbia University, discussed how data can empower health and what nurses can do to advance research during a session at the 43rd Annual Congress in Washington, DC.
Follow These Nursing Best Practices in Managing Patients Receiving CAR T-Cell Therapy
Kathleen McDermott, RN, BSN, OCN®, BMTCN®, of the Dana-Farber Cancer Institute, and coauthors presented the background for axicabtagene ciloleucel’s approval and nursing best practices for managing patients receiving CAR T-cell therapy during a poster session at the ONS 43rd Annual Congress in Washington, DC.
ONS 43rd Annual Congress Opening Honors Oncology Nurses’ Compassion, Innovation, and Dedication
Keynote speaker Lee Tomlinson, founder of the C.A.R.E. Effect, discussed his journey from cancer survivor to patient advocate, calling for compassionate care and thanking nurses for being the reason he is alive today, during the opening session at the 43rd Annual Congress in Washington, DC, on Thursday, May 17, 2018.
When Good Nurses Say Bad Things: Fighting Professional Incivility
Professional incivility, rudeness, and bullying are not new to the world of nursing. Nurses can see escalated teasing or bullying as “a rite of passage” or “earning our stripes.” However, changes in the workplace have shown that no matter what it’s called, bullying and professional incivility has no place in the working environment. Anne Ireland, MSN, RN, AOCN®, CENP, clinical director of the Solid Tumor Program at City of Hope National Medical Center in Duarte, CA, and Tracy Gosselin, PhD, RN, AOCN®, NEA-BC, chief nursing and patient care services officer at Duke University Hospital in Durham, NC, gave a lecture at the 43rd Annual Congress in Washington, DC, on their work with professional incivility and bullying and ways to teach nurses how to intervene and become powerful bystanders.
Using the Social Network: What Are the Professional Boundaries?
It’s hard to imagine life without social media, even though the active use of it is less than 15 years old. People use social media to stay connected to family and friends, for information on communities, and more. And although social media is most often used as a personal outlet, it has become much more prevalent in the professional realm as well.
Nurse Scientists Are Promoting the Future of Cancer Nursing Research at NINR and NCI
Many programs at the National Cancer Institute (NCI) are focused on cancer research, and support for cancer- and treatment-related symptoms and toxicities crosses a number of National Institutes of Health (NIH) organizations. Martha Matocha, PhD, program director and team lead of the National Institute of Nursing Research (NINR), and Ann O’Mara, PhD, RN, FAAN, program officer at NCI, provided tips and opportunities for nurses and how they can conduct or participate in cancer research programs during a session at the 43rd Annual Congress in Washington, DC.
Creating an Effective CV and Resume to Land the Job
Heather Costa, PHR, SHRM-CP, a nurse recruiter, and Precious Suchora Farroni, PHR, SHRMCP, an advanced practice recruiter, both from Ohio State University Wexner Medical Center, helped nurse attendees differentiate between a resume and a curriculum vitae (CV), offered tips to make both stand out, and provided tips to help boost professional profiles.
Nontraditional Roles in Oncology Nursing
The nursing profession has long been an incubator of innovation. Nurses are continually blazing new trails in clinical care, research, and administration, and the landscape is no different in the specialty of oncology. This article provides an overview of three non-traditional roles in oncology nursing: nurse navigation, nursing informatics, and research nursing.
Everything You Need to Know About Awards, Grants, and Scholarships
Oncology nurses seeking to further their education, earn continuing education credits, perform research, or implement professional projects are encouraged to apply for funding through the ONS Foundation, a charitable arm of ONS. Linda Worrall, RN, MSN, executive director of the ONS Foundation, presented an overview of their many awards, grants, and scholarships.
Best Practices for Abstract Writing and Presentation
The development of an abstract, poster, or podium presentation is a significant undertaking. Presenting the scope of your work in a concise and effective way can be daunting, but it does not have to be. Erica Fischer-Cartlidge, MSN, CNS, CBCN®, AOCNS®, a clinical nurse specialist at Memorial Sloan Kettering Cancer Center, provided advice on abstract writing and presentation.
An Insider’s Guide to Getting Published
One of the primary vehicles for sharing your expertise with colleagues and peers is to publish a professional article. This process may seem daunting and difficult—an impression that no doubt deters many oncology nurses from pursuing it. But the truth is that getting published is a feasible goal. It is also one that enhances your professional development.
Oncology Treatments and Trends Continue to Change Rapidly
“This has been a historic year in oncology pharmacology,” Rowena Schwartz, PharmD, BCOP, associate professor at the University of Cincinnati, told the audience during a session at the 42nd Annual Congress in Denver, CO. “There were new drugs, yes, but we’re really learning how to use the drugs that we have.”
Personalize Quality-of-Life Measures to Improve Patient Experiences
Quality of life (QOL) is a complicated construct and has been defined many ways. Barbara Anne Biedrzycki, PhD, CRNP, AOCNP®, of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, presented the following view: “Quality of life is achieved when our hopes are matched and fulfilled by our experiences.” She encouraged participants to have a holistic perspective of QOL but to keep in mind that QOL is very individualized—its definition and meaning are different to each individual, and each person finds some factors to be more important than others.
Improve Patient Safety by Defining and Refining Nurse Competencies
Carole Elledge, DNP, RN, AOCN®, clinical program specialist at Methodist Hospital in San Antonio, TX, described the concept of nursing competencies with a kitchen metaphor: “It’s kind of like baking a cake. If you’re going to bake a cake, you need all the ingredients.” For nurses, she said, the ingredients of competency include not only hands-on clinical skills, but also an ability to see past the disease, compassion, critical thinking, self-motivation, patience and insight, leadership, a team approach, and more. “There’s much more to competency than just skills.”